The Top 10 rare disease companies globally, ranked by worldwide orphan drug sales for 2018. Celgene takes top spot, followed by Roche and Novartis.
Made with Visme Infographic Maker
written on 08.02.2021
Top 10 Global Rare Disease Companies
Similar Facts and Figures
Biotech / Top 7 IPOs in 2020
Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you the seven…
Global Medical Cannabis Regulatory Landscape
The global regulatory landscape for medical cannabis, showing the countries in which medical cannabis and…
Top 10 Global Orphan Drug Companies Ranking 2017
The top 10 companies in the world ranked by global orphan drug sales and market share in 2017. Swiss giants…
Top Drugs Globally in 2019 by Sales
The world’s bestselling treatments for 2019 by sales in USD billions. AbbVie’s Humira is out in front…
Alzheimer’s Disease R&D Expenditure Snapshot 2019
Alzheimer’s drugs represent a high-risk, high-reward proposition for global pharma. As David H. Crean…
2019 WHO Essential Medicines List: 28 New Additions
The WHO has published its most recent edition of the Essential Medicines List in July 2019. On the list are 28 new…
Aducanumab Approval / Opening the Floodgates for a New Era of Alzheimer’s Treatment?
With the US FDA’s controversial recent decision to approve Biogen and Eisai’s aducanumab – the first approval…
Global / Five Ways That AI Can Transform Pharma Market Access
Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland outlines how AI has already begun…
Vaccines / Industry Warns of Manufacturing Bottlenecks; Specific Data Still Lacking
Big Pharma’s representatives are warning of upcoming bottlenecks in the COVID-19 vaccine manufacturing supply…